BUSINESS CASE | Transparency policy 0070

April 8, 2024

Have a look at this Business Case where Asphalion provided a leading global pharmaceutical company with full regulatory support for the management of Policy 0070 for a new active substance on the Centralized Procedure (CP) registration.

Thanks to our extensive track record of over 20 years, at Asphalion we can assist you in selecting the optimal strategy, optimizing costs and enhancing time-to-market, as well as with all other kind of activities and projects.

CASE STUDY ANALYSIS: BUSINESS CASE TRANSPARENCY POLICY 0070 Asphalion

For further information you can contact us at: info@asphalion.com

Search News & Events

  • Filter by category

Share

Related news and events

HORIZON | siNPAIN meeting in Reykjavík

The objective of this project is to create a siRNA-combined advanced therapy, which will allow a more personalised treatment for different stages of osteoarthritis.  All siNPAIN partners are working hard to develop efficient therapy to improve the quality of life of those affected by osteoarthritis, a chronic joint condition that affects more and more people every year.

EVENT | Symposium AEFI 2024

¡Mañana arranca el 42º Symposium de AEFI! No olvidéis visitarnos en la mesa 6 para conocer de todos los servicios que ofrecemos. Os recordamos los

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting